TRANSLATIONAL PROTEOMICS

TRANSLATIONAL PROTEOMICS

Coulombe Lab

News
Team
 
 
Polymerase MRI

Creating new generation diagnostics for precision medicine

Discovery

We identify and characterize proteins, protein modifications and protein interactions that can serve as biomarkers for various physiological and disease conditions

Assay

We develop automatable mass spectrometry-based methods to quantify biomarkers with high specificity, sensitivity and reproducibility

Validation

We quantify variations in biomarker levels across patient cohorts and establish correlations with physiological conditions, disease progression, response to treatment, etc.

Dissemination

We make our methods publicly available through publication in scientific journals immediately after validation, some being made available to health centers and clinics through our corporate partner Nuclea Biotechnology (Cambridge, USA)

Impact

Our methods contribute to the development of precision medicine for the benefit of patients around the world

Contact

Benoit Coulombe
Director, Translational Proteomics Research Unit
Director, IRCM Proteomics Discovery Platform
Full Research Professor, Department of Biochemistry and Molecular Medicine, Université de Montréal
benoit.coulombe@ircm.qc.ca
IRCM
Institut de recherches cliniques de Montréal (IRCM)
110 avenue des Pins Ouest
Montréal (Quebec) H2W 1R7
 
Laboratory: 514-987-5699
Office: 514-987-5662